Results on new AIDS drugs bring cautious optimism.
Cohen
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000821:virology; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects* / Q000502:physiology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir; D011725:Pyridines / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D019438:Ritonavir; D013844:Thiazoles / Q000627:therapeutic use; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014766:Viremia
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D011725:Pyridines; D012367:RNA, Viral; D013844:Thiazoles; D019469:Indinavir; D014633:Valine; D019438:Ritonavir